Today shortly before the closing bell, Regenicin, Inc. announces it is in advanced discussions with various developers in the State of Florida to determine the most strategic location and best partners to establish research facilities. Sites presently being considered are world-class research and technology parks, which will allow Regenicin to collaborate with leading centers of excellence in the academic, research, and healthcare arenas.
Regenicin is pursuing opportunities to lease new facilities that will not only accommodate the present demands for state-of-the-art lab space, but will also address the projected growth needs the company foresees as it executes its business plan.
Regenicin believes the state of Florida is not only an exciting new destination, but will also offer many appealing amenities with logistical and financial considerations for the biotech and life sciences industries. The company hopes to announce its site selection in the near future.
Let us hear your thoughts: Regenicin, Inc. Message Board